Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma

Jay P. Reddy, Curtis A. Pettaway, Lawrence B. Levy, Lance C. Pagliaro, Pheroze Tamboli, Priya Rao, Isuru Jayaratna, Karen E. Hoffman

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective: To identify factors associated with regional recurrence after lymph node dissection (LND) for squamous cell carcinoma (SCC) to determine which patients might benefit from adjuvant therapy. Patients and Methods: Men who underwent LND for penile SCC from 1977 to 2014 were identified from an institutional database. Kaplan–Meier curves estimated recurrence-free survival (RFS) calculated from the date of LND. Cox regression models evaluated the association between RFS and patient and tumour characteristics. Results: In all, 182 men who underwent LND for penile SCC were identified. The median patient age was 62 years and the median follow-up was 4.2 years. After LND 34 men had regional recurrence, of which 24 developed isolated regional recurrences without distant metastasis. The median RFS was 5.7 months, and the 3-year RFS rate was 70%. On univariate analysis, lymphovascular invasion, clinical and pathological nodal stage, pathological inguinal laterality, pelvic nodal involvement, lymph node density ≥5.2%, ≥3 pathologically involved lymph nodes, and extranodal extension (ENE) were associated with worse RFS (all P < 0.05). On multivariate analysis, clinical N3 disease [adjusted hazard ratio (AHR)] 3.53, 95% confidence interval (CI) 1.68–7.45; P = 0.001), ≥3 pathologically involved lymph nodes (AHR 3.78, 95% CI 2.12–6.65; P < 0.001), and ENE (AHR 3.32, 95% CI 1.93–5.76; P < 0.001) were associated with worse RFS. The 3-year RFS for patients with cN0, cN1, cN2, and cN3 disease was 91.7%, 64.5%, 54.7%, and 38.3%, respectively. For men with ≥3 involved nodes, the 3-year RFS was 17% vs 82.4% in men with <3 involved nodes. The 3-year RFS was 29.7% in men with ENE and 85.7% in men without ENE. Conclusion: The presence of clinical N3 disease, ≥3 pathologically involved lymph nodes, and ENE was associated with worse RFS. As regional recurrence portends a dismal prognosis with few salvage options, adjuvant therapies should be developed for men with the aforementioned adverse factors.

Original languageEnglish (US)
Pages (from-to)591-597
Number of pages7
JournalBJU International
Volume119
Issue number4
DOIs
StatePublished - Apr 1 2017

Fingerprint

Lymph Node Excision
Squamous Cell Carcinoma
Recurrence
Survival
Lymph Nodes
Confidence Intervals
Groin
Proportional Hazards Models
Multivariate Analysis
Survival Rate
Databases

Keywords

  • lymph node dissection
  • penile cancer
  • radiation
  • recurrence

ASJC Scopus subject areas

  • Urology

Cite this

Reddy, J. P., Pettaway, C. A., Levy, L. B., Pagliaro, L. C., Tamboli, P., Rao, P., ... Hoffman, K. E. (2017). Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma. BJU International, 119(4), 591-597. https://doi.org/10.1111/bju.13686

Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma. / Reddy, Jay P.; Pettaway, Curtis A.; Levy, Lawrence B.; Pagliaro, Lance C.; Tamboli, Pheroze; Rao, Priya; Jayaratna, Isuru; Hoffman, Karen E.

In: BJU International, Vol. 119, No. 4, 01.04.2017, p. 591-597.

Research output: Contribution to journalArticle

Reddy, JP, Pettaway, CA, Levy, LB, Pagliaro, LC, Tamboli, P, Rao, P, Jayaratna, I & Hoffman, KE 2017, 'Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma', BJU International, vol. 119, no. 4, pp. 591-597. https://doi.org/10.1111/bju.13686
Reddy, Jay P. ; Pettaway, Curtis A. ; Levy, Lawrence B. ; Pagliaro, Lance C. ; Tamboli, Pheroze ; Rao, Priya ; Jayaratna, Isuru ; Hoffman, Karen E. / Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma. In: BJU International. 2017 ; Vol. 119, No. 4. pp. 591-597.
@article{70c8172cd726409aa7fb0495d09a095a,
title = "Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma",
abstract = "Objective: To identify factors associated with regional recurrence after lymph node dissection (LND) for squamous cell carcinoma (SCC) to determine which patients might benefit from adjuvant therapy. Patients and Methods: Men who underwent LND for penile SCC from 1977 to 2014 were identified from an institutional database. Kaplan–Meier curves estimated recurrence-free survival (RFS) calculated from the date of LND. Cox regression models evaluated the association between RFS and patient and tumour characteristics. Results: In all, 182 men who underwent LND for penile SCC were identified. The median patient age was 62 years and the median follow-up was 4.2 years. After LND 34 men had regional recurrence, of which 24 developed isolated regional recurrences without distant metastasis. The median RFS was 5.7 months, and the 3-year RFS rate was 70{\%}. On univariate analysis, lymphovascular invasion, clinical and pathological nodal stage, pathological inguinal laterality, pelvic nodal involvement, lymph node density ≥5.2{\%}, ≥3 pathologically involved lymph nodes, and extranodal extension (ENE) were associated with worse RFS (all P < 0.05). On multivariate analysis, clinical N3 disease [adjusted hazard ratio (AHR)] 3.53, 95{\%} confidence interval (CI) 1.68–7.45; P = 0.001), ≥3 pathologically involved lymph nodes (AHR 3.78, 95{\%} CI 2.12–6.65; P < 0.001), and ENE (AHR 3.32, 95{\%} CI 1.93–5.76; P < 0.001) were associated with worse RFS. The 3-year RFS for patients with cN0, cN1, cN2, and cN3 disease was 91.7{\%}, 64.5{\%}, 54.7{\%}, and 38.3{\%}, respectively. For men with ≥3 involved nodes, the 3-year RFS was 17{\%} vs 82.4{\%} in men with <3 involved nodes. The 3-year RFS was 29.7{\%} in men with ENE and 85.7{\%} in men without ENE. Conclusion: The presence of clinical N3 disease, ≥3 pathologically involved lymph nodes, and ENE was associated with worse RFS. As regional recurrence portends a dismal prognosis with few salvage options, adjuvant therapies should be developed for men with the aforementioned adverse factors.",
keywords = "lymph node dissection, penile cancer, radiation, recurrence",
author = "Reddy, {Jay P.} and Pettaway, {Curtis A.} and Levy, {Lawrence B.} and Pagliaro, {Lance C.} and Pheroze Tamboli and Priya Rao and Isuru Jayaratna and Hoffman, {Karen E.}",
year = "2017",
month = "4",
day = "1",
doi = "10.1111/bju.13686",
language = "English (US)",
volume = "119",
pages = "591--597",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma

AU - Reddy, Jay P.

AU - Pettaway, Curtis A.

AU - Levy, Lawrence B.

AU - Pagliaro, Lance C.

AU - Tamboli, Pheroze

AU - Rao, Priya

AU - Jayaratna, Isuru

AU - Hoffman, Karen E.

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Objective: To identify factors associated with regional recurrence after lymph node dissection (LND) for squamous cell carcinoma (SCC) to determine which patients might benefit from adjuvant therapy. Patients and Methods: Men who underwent LND for penile SCC from 1977 to 2014 were identified from an institutional database. Kaplan–Meier curves estimated recurrence-free survival (RFS) calculated from the date of LND. Cox regression models evaluated the association between RFS and patient and tumour characteristics. Results: In all, 182 men who underwent LND for penile SCC were identified. The median patient age was 62 years and the median follow-up was 4.2 years. After LND 34 men had regional recurrence, of which 24 developed isolated regional recurrences without distant metastasis. The median RFS was 5.7 months, and the 3-year RFS rate was 70%. On univariate analysis, lymphovascular invasion, clinical and pathological nodal stage, pathological inguinal laterality, pelvic nodal involvement, lymph node density ≥5.2%, ≥3 pathologically involved lymph nodes, and extranodal extension (ENE) were associated with worse RFS (all P < 0.05). On multivariate analysis, clinical N3 disease [adjusted hazard ratio (AHR)] 3.53, 95% confidence interval (CI) 1.68–7.45; P = 0.001), ≥3 pathologically involved lymph nodes (AHR 3.78, 95% CI 2.12–6.65; P < 0.001), and ENE (AHR 3.32, 95% CI 1.93–5.76; P < 0.001) were associated with worse RFS. The 3-year RFS for patients with cN0, cN1, cN2, and cN3 disease was 91.7%, 64.5%, 54.7%, and 38.3%, respectively. For men with ≥3 involved nodes, the 3-year RFS was 17% vs 82.4% in men with <3 involved nodes. The 3-year RFS was 29.7% in men with ENE and 85.7% in men without ENE. Conclusion: The presence of clinical N3 disease, ≥3 pathologically involved lymph nodes, and ENE was associated with worse RFS. As regional recurrence portends a dismal prognosis with few salvage options, adjuvant therapies should be developed for men with the aforementioned adverse factors.

AB - Objective: To identify factors associated with regional recurrence after lymph node dissection (LND) for squamous cell carcinoma (SCC) to determine which patients might benefit from adjuvant therapy. Patients and Methods: Men who underwent LND for penile SCC from 1977 to 2014 were identified from an institutional database. Kaplan–Meier curves estimated recurrence-free survival (RFS) calculated from the date of LND. Cox regression models evaluated the association between RFS and patient and tumour characteristics. Results: In all, 182 men who underwent LND for penile SCC were identified. The median patient age was 62 years and the median follow-up was 4.2 years. After LND 34 men had regional recurrence, of which 24 developed isolated regional recurrences without distant metastasis. The median RFS was 5.7 months, and the 3-year RFS rate was 70%. On univariate analysis, lymphovascular invasion, clinical and pathological nodal stage, pathological inguinal laterality, pelvic nodal involvement, lymph node density ≥5.2%, ≥3 pathologically involved lymph nodes, and extranodal extension (ENE) were associated with worse RFS (all P < 0.05). On multivariate analysis, clinical N3 disease [adjusted hazard ratio (AHR)] 3.53, 95% confidence interval (CI) 1.68–7.45; P = 0.001), ≥3 pathologically involved lymph nodes (AHR 3.78, 95% CI 2.12–6.65; P < 0.001), and ENE (AHR 3.32, 95% CI 1.93–5.76; P < 0.001) were associated with worse RFS. The 3-year RFS for patients with cN0, cN1, cN2, and cN3 disease was 91.7%, 64.5%, 54.7%, and 38.3%, respectively. For men with ≥3 involved nodes, the 3-year RFS was 17% vs 82.4% in men with <3 involved nodes. The 3-year RFS was 29.7% in men with ENE and 85.7% in men without ENE. Conclusion: The presence of clinical N3 disease, ≥3 pathologically involved lymph nodes, and ENE was associated with worse RFS. As regional recurrence portends a dismal prognosis with few salvage options, adjuvant therapies should be developed for men with the aforementioned adverse factors.

KW - lymph node dissection

KW - penile cancer

KW - radiation

KW - recurrence

UR - http://www.scopus.com/inward/record.url?scp=84998706915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84998706915&partnerID=8YFLogxK

U2 - 10.1111/bju.13686

DO - 10.1111/bju.13686

M3 - Article

C2 - 27753187

AN - SCOPUS:84998706915

VL - 119

SP - 591

EP - 597

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 4

ER -